NIFTY  8,435.10  0.22%
  SENSEX  27,308.60  0.19%
 CURRENCY  Rs  68.08/$ 72.37/€, 83.49/£
  GOLD  28,600.00  -0.66%
  SILVER  41,368.00  -1.50%
  DAX  11,599.40  0.51%
  FTSE  7,247.61  0.38%
  CAC  4,853.40  -0.11%
  HANG SENG  23,050.00  -0.21%
  NIKKEI  19,072.20  0.94%
  Shanghai Composite  3,101.30  -0.21%
  DOW JONES  19,804.70  -0.11%
  NASDAQ  5,555.65  0.31%
  S&P 500  2,271.89  0.18%
MINDTREE Q3 : Consol Net Profit At Rs 103 Cr Vs Rs 14.1 Lk YoY MINDTREE Q3 : Consol Income From Software Svcs At Rs 1295 Cr Vs Rs 1210 Cr YoY

Aurobindo To Set Up Exclusive Hyd Plant

Video:

Play this video

March 6: Following Aurobindo Pharma's Rs.220 crore deal to acquire Actavis’ Western European operations, sources tell Bloomberg TV India that the company now plans to set up another drug facility in Hyderabad. The move has been strategically planned so that it can cut costs and also manufacture some of Actavis’ products domestically. The transfer of licenses is expected to be completed in six months. Priya Sheth shares a detailed report on the same.